Electronic cigarettes: A systematic review of available studies on health risk assessment

Reviews on Environmental Health

Volumn 33, Issue 1, 2018, Pages 43-52

  Zulkifli, Aziemah ^a   Abidin, Emilia Zainal ^a   Abidin, Najihah Zainol ^a   Nordin, Amer Siddiq Amer ^b   Praveena, Sarva Mangala ^a   Ismail, Sharifah Norkhadijah Syed ^a   Rasdi, Irniza ^a   Karuppiah, Karmegam ^a   Rahman, Anita Abd ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

e liquid; electronic cigarettes (e cigarettes); hazard quotient; health risk assessment (HRA); margin of exposure; risk characterization

Indexed keywords

ELECTRONIC CIGARETTE; HUMAN; RISK ASSESSMENT;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; RISK ASSESSMENT;

EID: 85010057615     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/reveh-2015-0075     Document Type: Review

References (41)

1. Dawkins L, Turner J, Roberts A, Soar K. "Vaping" profiles and preferences: an online survey of electronic cigarette users. Addiction 2013;108(6):1115-25.
2. Dockrell M, Morrison R, Bauld L, McNeill A. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 2013;15(10):1737-44.
3. Adkison SE, O'Connor RJ, Bansal-Travers M, Hyland A, Borland R, et al. Electronic nicotine delivery systems: International Tobacco Control Four-Country Survey. Am J Prev Med 2013;44(3):207-15.
4. Basis S, Regulation TP, Report T, Group WHOS. WHO Study Group on Tobacco Product Regulation. Report on the scientific basis of tobacco product regulation: third report of a WHO Study Group. World Health Organ Tech Rep Ser 2009;(955):1-41.
5. Regan K, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the "e-cigarette" in the USA. Tob Control 2011:19-23.
6. King BA, Patel R, Nguyen KH, Dube SR. Trends in awareness and use of electronic cigarettes among US adults, 2010-2013. Nicotine Tob Res 2015;17(2):219-27.
7. Palipudi KM, Morton J, Mbulo L, Bunnell R, Blutcher NG, et al. Awareness and current use of electronic cigarettes in Indonesia, Malaysia, Qatar, and Greece: findings from 2011-2013 Global Adult Tobacco Surveys. Nicotine Tob Res 2016;18(4):501-7.
8. Global Adult Tobacco Survey Greece (GATS). 2013. Available at: http://www.who.int/tobacco/surveillance/survey/gats/ grc-country-report.pdf [accessed on 9 February, 2016].
9. Global Adult Tobacco Survey Malaysia (GATS). 2011. Available at: http://www.moh.gov.my/images/gallery/Report/GATS- Malaysia.pdf [accessed on 9 February, 2016].
10. Global Adult Tobacco Survey Indonesia (GATS). 2011. Available at http://www.who.int/tobacco/surveillance/survey/gats/ indonesia-report.pdf [accessed on 9 February, 2016].
11. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am J Prev Med 2011;40(4):472-5.
12. Pisinger C, Dossing M. A systematic review of health effects of electronic cigarettes. Prev Med (Baltim) 2014;69C:248-60.
13. Hutzler C, Paschke M, Kruschinski S, Henkler F, Hahn JR, et al. Chemical hazards present in liquids and vapors of electronic cigarettes. Arch Toxicol 2014;88(7):1295-308.
14. International Agency for Research on Cancer. IARC. 2010. Retrieved at http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/ TobaccoProductsScientificAdvisoryCommittee/UCM215717.pdf [accessed on 9 February, 2016].
15. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013;15(1):158-66.
16. AEMSA. (2014). E-Liquid manufacturing standards (Version 1.8, pp. 1-10). Author.
17. Laugesen M. Safety Report on the RuyanR e-cigarette Cartridge and Inhaled Aerosol. Heal NZ 2008;(October 2008):1-23.
18. Kim HJ, Shin HS. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2013;1291:48-55.
19. Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an Internet survey. Drug Alcohol Rev 2013;32(2):133-40.
20. Westenberger BJ. Evaluation of e-cigarettes. St. Lous, MO: FDA. DPATR-FY-09-23, 2009.
21. Stepanov I, Jensen J, Hatsukami D, Hecht SS. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res 2006;8(2):309-313.
22. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. v. 89. IARC; Lyon, FR: 2007. Smokeless tobacco and tobacco-specific nitrosamines; 421-583.
23. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11(6):559-603.
24. Kienhuis AS, Soeteman-Hernandez LG, Bos PM, Cremers HW, Klerx WN, et al. Potential harmful health effects of inhaling nicotine-free shisha-pen vapor: a chemical risk assessment of the main components propylene glycol and glycerol. Tob Induc Dis 2015;13(1):15.
25. Farsalinos K, Voudris V, Poulas K. Are metals emitted from electronic cigarettes a reason for health concern? a risk-assessment analysis of currently available literature. Int J Environ Res Public Health 2015;12(5):5215-32.
26. Hahn J, Monakhova YB, Hengen J, Kohl-Himmelseher M, SchUssler J, et al. Electronic cigarettes: overview of chemical composition and exposure estimation. Tob Induc Dis 2014;12(23). Doi: 10.1186/s12971-014-0023-6.
27. Exponent. NJOY e-cigarette health risk assessment. 2009. Available at: http://truthaboutecigs.com/science/5.php [accessed on 15 October, 2015].
28. Zhu S-H, Sun JY, Bonnevie E, Cummins SE, Gamst A, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014;23 (suppl 3):iii3-9.
29. United States Environment al Protection Agency. 2015. Available at: http://www2.epa.gov/risk/human-health-risk-assessment [accessed on 9 February, 2016].
30. EPA (United States Environmental Protection Agency). Methodology for deriving ambient water quality criteria for the protection of human health. Washington, DC: EPA. EPA822-B-00-004, 2000.
31. Etter J-F. Electronic cigarettes: a survey of users. BMC Public Health 2010;10(1):231.
32. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv drug Saf 2014;5(2):67-86.
33. Orr MS. Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future. Tob Control 2014;23(Suppl 2):ii18-22.
34. Trehy ML, Ye W, Hadwiger ME, Moore TW, Allgire JF, et al. Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chromatogr Relat Technol 2011;34(14):1442-58.
35. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23(2):133-9.
36. Watanabe KH, Djordjevic MV, Stellman SD, Toccalino PL, Austin DF, et al. Incremental lifetime cancer risks computed for benzo [a] pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data. Regul Toxicol Pharm 2009;55(2):123-33.
37. Pankow JF, Watanabe KH, Toccalino PL, Luo W, Austin DF. Calculated cancer risks for conventional and "potentially reduced exposure product" cigarettes. Cancer Epidemiol Biomarkers Prev 2007;16(3):584-92.
38. Xie J, Marano KM, Wilson CL, Liu H, Gan H, et al. A probabilistic risk assessment approach used to prioritize chemical constituents in mainstream smoke of cigarettes sold in China. Regul Toxicol Pharm 2012;62(2):355-62.
39. Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control 2003;12(4):424-30.
40. US EPA. HH: Risk characterization. 2015. Available at http:// www.epa.gov/region8/hh-risk-characterization [accessed on 1 December, 2015].
41. ILSI Risk Science Institute. The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. Inhal Toxicol 2000;12:1-17.